4th Annual Northeast Dermatology Regional Conference

The Northeast Dermatology Conference is a live educational activity designed for dermatology nurse practitioners, physician assistants, and other advanced practice clinicians seeking to enhance their knowledge and clinical competency in the diagnosis, treatment, and management of dermatologic disease. This comprehensive program features expert-led presentations, case-based discussions, procedural education, and evidence-based updates addressing a broad range of medical, surgical, pediatric, cosmetic, and inflammatory dermatology topics.

Educational content focuses on emerging therapies, biologics, dermoscopy, procedural techniques, skin cancer detection, pediatric dermatology, skin of color, inflammatory disease management, aesthetic treatments, and interdisciplinary care strategies. Faculty will provide practical clinical insights and real-world applications intended to support improved diagnostic accuracy, therapeutic decision-making, procedural confidence, and patient-centered care.

The conference is designed to address current professional practice gaps related to rapidly evolving treatment options, expanding therapeutic pipelines, procedural advancements, and the increasing complexity of dermatologic patient care. Through interactive learning and expert guidance, participants will gain clinically relevant strategies that can be incorporated into daily practice to improve the quality, safety, and effectiveness of dermatologic care.

Target Audience

This activity is designed for an audience of nurses practitioners and physician associates.

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Apply evidence-based diagnostic and treatment strategies for common and complex dermatologic diseases encountered in clinical practice. 
  • Integrate emerging therapies, biologics, and evolving treatment guidelines into individualized patient management plans for inflammatory skin diseases. 
  • Improve diagnostic accuracy through enhanced recognition of dermoscopic patterns, cutaneous manifestations of systemic disease, and atypical dermatologic presentations. 
  • Demonstrate improved competency in dermatologic procedures, aesthetic treatments, suturing techniques, and complication management. 
  • Evaluate and apply clinical research findings and statistical outcomes to evidence-based dermatology practice. 
  • Implement culturally competent and inclusive dermatologic care strategies for pediatric patients and patients with skin of color. 
  • Strengthen interdisciplinary collaboration in the management of dermatologic conditions with systemic involvement, including psoriatic arthritis and autoimmune disease. 
  • Incorporate risk management, leadership, and professional practice principles to improve patient safety and optimize advanced practice provider performance.

 

Commercial Support
There is no commercial support for this activity.

Course summary
Available credit: 
  • 21.50 AANP Contact Hours

    Nurse Practitioners

    This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and .  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 21.50 contact hour(s) (which includes 0.00 hour(s) of pharmacology).

  • 22.25 AAPA Category 1 CME

    AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 22.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  • 22.25 Attendance

    Credits: 22.25

Course opens: 
05/28/2026
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0
May 28 - 31, 2026 in Groton, Connecticut
United States

Planners and Reviewers
AKH Inc Staff and Planners
BCI Management & Communications Staff and Planners

All of the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product 
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer 
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Reviewer(s)

Dorothy Caputo, MA BSN RN

has no relevant financial relationships to disclose at this time.

Bernadette Maker, MSN, APRN-BC, NP-C

has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)

Tracee Blackburn, DMSc, MSIM, PA-C

has no relevant financial relationships to disclose at this time.

Sylvana Brickley

has no relevant financial relationships to disclose at this time.

Nicole Chevalier, PA-C

has no relevant financial relationships to disclose at this time.

Ellie Christianson, FNP-BC APRN

has a financial relationship (Speaker) with Leo;.
has a financial relationship (Speaker) with Arcutis;.
has a financial relationship (Consultant) with Organon;.
has a financial relationship (Consultant) with Incyte;.

Victor Czerkasij, DNP, DCNP, FNP-C, CWCP

has a financial relationship (Speaker) with Sun Pharma;.
has a financial relationship (Speaker) with Abbvie;.
has a financial relationship (Speaker) with Johnson & Johnson;.
has a financial relationship (Speaker) with Sanofi/Regeneron;.
has a financial relationship (Speaker) with Lilly;.
has a financial relationship (Speaker) with UCB;.
has a financial relationship (Speaker) with Galderma;.

ERIK DOMINGUES, Erik Domingues, MD FAAD

has a financial relationship (Speaker) with Abbvie;.
has a financial relationship (Consultant) with Abbvie;.
has a financial relationship (Consultant) with Arcutis;.
has a financial relationship (Speaker) with Arcutis;.
has a financial relationship (Advisor) with BMS;.
has a financial relationship (Speaker) with BMS;.
has a financial relationship (Advisor) with Castle Biosciences;.
has a financial relationship (Advisor) with Incyte;.
has a financial relationship (Speaker) with Incyte;.
has a financial relationship (Speaker) with Galderma;.
has a financial relationship (Advisor) with Johnson & Johnson;.
has a financial relationship (Speaker) with Kowa;.
has a financial relationship (Advisor) with LEO Pharma;.
has a financial relationship (Advisor) with Pelthos;.
has a financial relationship (Speaker) with Pelthos;.
has a financial relationship (Advisor) with Pfizer;.
has a financial relationship (Speaker) with Pfizer;.
has a financial relationship (Advisor) with UCB;.
has a financial relationship (Speaker) with UCB;.
has a financial relationship (Advisor) with Veradermics;.

Mary Elliott, PhD, MMSc, PA-C

has a financial relationship (Speaker) with Johnson & Johnson;.
has a financial relationship (Advisor) with Johnson & Johnson;.

Jennifer Flynn, CPHRM

has no relevant financial relationships to disclose at this time.

Tristan hasbargen, MMS, PA-C

has a financial relationship (Advisor) with Eli Lilly;.
has a financial relationship (Speaker) with Eli Lilly;.
has a financial relationship (Advisor) with Castle Bioscience;.
has a financial relationship (Speaker) with Castle;.
has a financial relationship (Advisor) with LEO;.
has a financial relationship (Advisor) with Sanofi;.
has a financial relationship (Advisor) with Sanofi;.
has a financial relationship (Advisor) with UCB;.
has a financial relationship (Speaker) with UCB;.
has a financial relationship (Advisor) with J&J;.
has a financial relationship (Advisor) with Incyte;.
has a financial relationship (Advisor) with Novartis;.
has a financial relationship (Advisor) with Regeneron;.
has a financial relationship (Advisor) with SUN Pharma;.
has a financial relationship (Advisor) with POCN;.

Nathaniel Jellinek, MD, FAAD, FACMS

has no relevant financial relationships to disclose at this time.

Ashfaq Marghoob, MD

has no relevant financial relationships to disclose at this time.

Meagen McCusker

has a financial relationship (Consultant) with AbbVie; Amgen; Arcutis; Boehringer Ingelheim; Eli Lilly; Galderma; Incyte; Johnson & Johnson; Leo Pharmaceuticals; Novartis; Dermavant; Pfizer; Sanofi-Genzyme/Regeneron; Sun Pharmaceuticals; UCB;.
has a financial relationship (Advisor) with AbbVie; Amgen; Arcutis; Boehringer Ingelheim; Eli Lilly; Galderma; Incyte; Johnson & Johnson; Leo Pharmaceuticals; Novartis; Dermavant; Pfizer; Sanofi-Genzyme/Regeneron; Sun Pharmaceuticals; UCB;.
has a financial relationship (Speaker) with AbbVie; Amgen; Arcutis; Eli Lilly; Galderma; Incyte; Leo Pharmaceuticals; Dermavant; Pfizer; Sanofi-Genzyme/Regeneron; UCB;.

Michael Payette, MD, MBA

has a financial relationship (Consultant) with Abbvie;.
has a financial relationship (Consultant) with Novartis;.
has a financial relationship (Consultant) with UCB;.
has a financial relationship (Speaker) with Abbvie;.
has a financial relationship (Speaker) with Novartis;.
has a financial relationship (Speaker) with UCB;.

Lori Robertson, MSN, PHN, ARN, FNP-C

has a financial relationship (Independent contractor (including contracted research)) with Galderma;.

Mona Shahriari, MD

has a financial relationship (Consultant) with AbbVie, Alumis, Amgen, Apogee, Arcutis, Bristol Myers Squibb, Organon, Oruka, Galderma, Pfizer, Incyte, Janssen, Leo Pharma, Lilly USA, Novartis, Sanofi-Genzyme, Regeneron, Takeda, UCB;.
has a financial relationship (Speaker) with Abbvie, Arcutis, Bristol Myers Squibb, Galderma, Lilly USA, Incyte, Janssen, Organon, Novartis, Pfizer, Galderma, UCB, Sanofi, Regeneron;.
has a financial relationship (Researcher) with CorEvitas Psoriasis and Atopic Dermatitis Registry, Incyte, Takeda, Abbvie, Oruka;.

Eingun Song

has a financial relationship (Advisor) with AbbVie, Alumis, Alphyn, Amgen, Apogee, Arcutis, BMS, Dermavant/Organon, Galderma, Incyte, Johnson&Johnson,LEO, Novartis, Ortho-dermatologics,Pfizer, Phothera, Sanofi & Regeneron, SUN, UCB, Takeda;.

Bruce Strober

has a financial relationship (Consultant) with AbbVie, Alumis, Almirall, Amgen, Apogee, Arcutis, Bristol-Myers-Squibb, CorEvitas, Dimagi, Immunovant, Johnson & Johnson, Leo, Eli Lilly, Neurocrine, Novartis, Oruka, Meiji Seika Pharma, Protagonist, Pfizer, UCB Pharma, Regeneron, Sanofi-Genzyme;.
has a financial relationship (Consultant) with selectION, Takeda;.
has a financial relationship (Individual stocks and stock options) with Mindera Health, selectION;.
has a financial relationship (Speaker) with AbbVie, Arcutis, Eli Lilly, Incyte, Johnson & Johnson, Regeneron, Sanofi-Genzyme;.
has a financial relationship (Independent contractor (including contracted research)) with CorEvitas Psoriasis and GPP Registries, Oruka, Incyte;.

Elizabeth Swanson, MD, FAAD

has a financial relationship (Advisor) with Abbvie, Almirall, Alphyn, Arcutis, Boehringer Ingelheim, Castle, Chiesi, Galderma, Incyte, J&J, Leo, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, Verrica;.
has a financial relationship (Speaker) with Abbvie, Arcutis, Galderma, Incyte, J&J, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, Verrica;.
has a financial relationship (Researcher) with Arcutis, Castle, Organon;.

Theresa Talens, Practice Owner, Dermatology Nurse Practioner

has no relevant financial relationships to disclose at this time.

Lyris Verdura-Dominic, BSN, MSN, APRN, FNP-BC

has a financial relationship (Independent contractor (including contracted research)) with Benev;.
has a financial relationship (Speaker) with Miracu;.
has a financial relationship (Speaker) with Speaker/Trainer/KOL- PharmaResearch Products Co., Ltd;.
has a financial relationship (Consultant) with HansBio Med / MINT;.
has a financial relationship (Independent contractor (including contracted research)) with Toskani;.
has a financial relationship (Speaker) with CAREStream America;.
has a financial relationship (Speaker) with Illari;.
has a financial relationship (Independent contractor (including contracted research)) with B.A.I. Biosciences, Inc. ;.
has a financial relationship (Independent contractor (including contracted research)) with Empire Medical Training;.
has a financial relationship (Independent contractor (including contracted research)) with Informa PLC;.
has a financial relationship (Independent contractor (including contracted research)) with Connecticut Dermatology NP & PA Organization;.
has a financial relationship (Independent contractor (including contracted research)) with Aesthetic Next LLC;.
has a financial relationship (Speaker) with Med-Aesthetics America, LLC;.
has a financial relationship (Speaker) with Medical Aesthetic Art Institute, LLC;.

melodie young, MSN, A/GNP-c, FSDNP

has a financial relationship (Speaker) with Johnson and Johnson;.
has a financial relationship (Speaker) with Eli LIlly;.
has a financial relationship (Speaker) with Sun Pharma;.
has a financial relationship (Speaker) with Amgen;.
has a financial relationship (Speaker) with Arcutis;.
has a financial relationship (Speaker) with Organon;.
has a financial relationship (Researcher) with Takeda;.
has a financial relationship (Speaker) with UCB;.
has a financial relationship (Researcher) with Abbvie;.
has a financial relationship (Researcher) with Eli Lilly;.
has a financial relationship (Researcher) with Oruka;.
has a financial relationship (Researcher) with Sanofi;.
has a financial relationship (Researcher) with Pfizer;.
has a financial relationship (Researcher) with Hunan Mabgeek ;.
has a financial relationship (Researcher) with Alumis;.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Connecticut Dermatology NP & PA Organization. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 22.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

 

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Connecticut Dermatology NP & PA Organization.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 21.50 contact hour(s) (which includes 12 hour(s) of pharmacology).

Available Credit

  • 21.50 AANP Contact Hours

    Nurse Practitioners

    This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and .  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 21.50 contact hour(s) (which includes 0.00 hour(s) of pharmacology).

  • 22.25 AAPA Category 1 CME

    AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 22.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  • 22.25 Attendance

    Credits: 22.25

Price

Cost:
$0.00
Please login or register to take this course.